Pay in 4 interest-free payments of $5.46 Learn more
Ships within 48 hours · Estimated delivery Aug 24 - Aug 29
It is unknown whether MOUNJARO causes thyroid C-cell tumors, including medullary thyroid carcinoma (MTC), in humans as human relevance of tirzepatide-induced rodent thyroid C-cell tumors has not been determined [see Warnings and Precautions (5.1) and Nonclinical Toxicology (13.1)]
They can support your energy levels, but a balanced diet and regular exercise are key to losing weight effectively.
AOD-9604 is not approved by the FDA, EMA, or any other regulatory authority for any indication
The most commonly reported adverse effects are the GI symptoms associated with tirzepatide (nausea, reduced appetite) plus the mild headache occasionally seen with AOD 9604
US$ 28.46
US$ 26.60
US$ 25.82
US$ 27.73
US$ 22.10
